Will Herrington

Professor Will Herrington is a clinician scientist and Professor of Trials and Epidemiology of Kidney Disease at the Nuffield Department of Population Health, University of Oxford, with an honorary consultancy at the Oxford Kidney Unit. He specializes in large-scale clinical trials and epidemiological research to understand kidney disease progression and its cardiovascular complications.

• Education: MA, MBBS, MD, FRCP, FERA

Research Interests: His work focuses on:

• Determinants of kidney disease development
• Role of adiposity in renal and cardiovascular outcomes
• Novel urine biomarkers for treatment response
• Meta-analyses of SGLT2 inhibitors
• Epidemiological studies in diverse populations

Article Trends: Recent work includes meta-analyses of empagliflozin in CKD, Mendelian randomization studies linking BMI to mortality, and methodological advancements in clinical trial design. Collaborations span cardiovascular and renal disciplines.

Scientific Awards: Recipient of the Professor David Kerr Clinician Scientist Award from both the Medical Research Council-UK and Kidney Research UK (2018-2022).

Leadership: Chair of the UK Renal Trials Network (2020-2024), Chief Investigator for EMPA-KIDNEY and EASi-KIDNEY trials, and contributor to European Society of Cardiology and KDIGO clinical guidelines.